US · Healthcare

Pyxis Oncology Inc (PYXS)

Biotechnology

Pyxis Oncology Inc (PYXS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PYXS

P/E ratio

25.00

Pyxis Oncology Inc (PYXS) — FAQ

What is PYXS's P/E ratio?

The price-to-earnings (P/E) ratio for Pyxis Oncology Inc (PYXS) is 25.00 (data as of 2026-05-23).

Does Pyxis Oncology Inc pay a dividend?

Dividend yield is not available in the current snapshot for Pyxis Oncology Inc (PYXS). Check the MyAverix Finance app for the latest dividend data.

What sector is Pyxis Oncology Inc in?

Pyxis Oncology Inc (PYXS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PYXS listed on?

PYXS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)